ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Breaking New Study: mRNA Vaccines Trigger 620% Heart Risk Surge in Young Men

Washington, DC (Newsworthy.ai) Monday Apr 14, 2025 @ 10:22 AM Eastern —

A groundbreaking new study published in the International Journal of Cardiovascular Research & Innovation is sounding alarms about the safety of COVID-19 mRNA vaccines, directly challenging claims from public health officials and raising urgent questions about transparency and trust. Using hard data from disease trends, patient outcomes, and immune system analysis from multiple research reports, the study reveals that heart inflammation risks tied to the vaccines may be far greater—and more dangerous—than previously reported, particularly among young men, shaking confidence in official narratives.

For example, South Korea’s massive 4.5 million-person study found a stunning 620% spike in myocarditis risk and a 175% jump in pericarditis risk after mRNA vaccination. That’s not a typo—six times the normal rate of heart inflammation, often hitting within days of the shot. Chest pain, racing hearts, and crippling fatigue are just the start—many cases morph into “myopericarditis,” a dangerous combination of heart and sac inflammation confirmed by MRI scans. Young men under 40, especially teens aged 12-24, are up to seven times more likely to exhibit these symptoms than girls their age.

These findings also paint a stark picture: the public may have been misled about the true costs of these vaccines. “Our findings demand a hard look at what we’ve been told,” said Dr. Kirk Milhoan, IMA Senior Fellow, Pediatric Cardiology and one of the study’s authors. “Transparency is non-negotiable when lives are at stake.”

“To get your papers published, you’ve had to say ‘safe and effective’ over and over, and that’s a real problem in our field,” added Jessica Rose, IMA Senior Fellow, Computational Biology and one of the study’s authors. “It’s shocking. People need to understand the dangers here. Political correctness has no place in medicine.”

The study’s bombshell conclusions specifically debunk three major claims pushed by health agencies:

  1. Vaccines Cause More Heart Issues Than the Virus: Contrary to assurances that COVID-19 infections posed a bigger threat for myocarditis (heart inflammation), the study shows mRNA vaccines like Pfizer and Moderna may trigger more cases than the virus itself, including during Omicron waves.

  2. Heart Risks Aren’t “Mild” or “Rare”: Health officials called vaccine-related myocarditis mild, short-lived, and uncommon. The study counters that these cases can be severe, long-lasting, and more frequent, with potential for lasting heart damage in some patients.

  3. Risks Outweigh Benefits: Agencies insisted the vaccines’ benefits far outweigh any downsides. The researchers argue the opposite, pointing to a higher-than-expected toll of vaccine-related harm that calls the ongoing push for mRNA shots into serious question.

This revelation lands as Americans grapple with growing distrust in institutions, from government to Big Pharma, including revelations that high-ranking CDC personnel may have deleted critical mRNA injury data. The study calls for immediate scrutiny of vaccine policies and a renewed focus on individual choice in healthcare decisions.

The full study, authored by M. Nathaniel Mead, Jessica Rose, William Makis, Kirk Milhoan, Nicolas Hulscher, and Peter A. McCullough can be found here.

Heart Risks Much Higher than Previously Reported; Younger Men Bear the Brunt of Growing Crisis

“Any doctor who has practiced medicine for any reasonable amount of time will view these findings as a major alarm. The continued use of mRNA risks generational harm to the American people.” – Dr. Kirk Milhoan

About Dr. Kirk Milhoan

Dr. Kirk Milhoan is a pediatric cardiologist with over 25 years of experience, based primarily in Kihei, Hawaii, and San Antonio, Texas. He holds a BA from Point Loma Nazarene University, a PhD in Cardiovascular Physiology from UC San Diego, and an MD from Jefferson Medical College. He completed his pediatric residency in the Air Force and a cardiology fellowship at San Diego Children’s Hospital. A former Air Force Lieutenant Colonel and flight surgeon, he’s board-certified in pediatric cardiology and has worked with hospitals like Methodist Hospital in San Antonio. Dr. Milhoan is also a Senior Fellow of Pediatric Cardiology for the Independent Medical Alliance (IMA).

About Dr. Jessica Rose

Dr. Jessica Rose holds a Bachelor’s degree in Applied Mathematics from Memorial University of Newfoundland, a Master’s degree in Immunology from the same institution, and a Ph.D. in Computational Biology from Bar-Ilan University in Israel. She completed two postdoctoral fellowships—one in Molecular Biology at the Hebrew University of Jerusalem and another in Biochemistry at the Technion – Israel Institute of Technology. Her expertise spans applied mathematics, immunology, computational biology, molecular biology, and biochemistry, making her a multidisciplinary researcher. Dr. Rose is also a Senior Fellow of Computational Biology for the Independent Medical Alliance (IMA) and a Brownstone Institute Fellow.

About the Independent Medical Alliance (IMA)

Formerly the Front Line COVID-19 Critical Care Alliance, the IMA has grown into America’s leading organization of frontline doctors, healthcare providers, and researchers advocating for full reform of government healthcare agencies, including transparency on conflicts of interest, pricing and payments, drug and vaccine injuries, and other essential reforms to restore trust in healthcare agencies.

Contact Lynne@imahealth.org.

This press release is distributed by the Newsworthy.ai™ Press Release Newswire - News Marketing Platform.™

The reference URL for this press release is located here Breaking New Study: mRNA Vaccines Trigger 620% Heart Risk Surge in Young Men.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.